|Articles|April 15, 2003
- BioPharm International-04-01-2003
- Volume 16
- Issue 4
Inside Washington: GMP Progress Report
Author(s)Jill Wechsler
by Jill Wechsler, BioPharm International Six months into its initiative to update manufacturing regulations, FDA announces a raft of changes covering warning letters, inspections, and comparability ? plus a fresh start on Part 11.
Advertisement
Articles in this issue
over 22 years ago
Virus Inactivation in the 1990s and into the 21st Centuryover 22 years ago
Getting Ready for Risk-Based GMPsover 22 years ago
GMP Issues: Breaking Groundover 22 years ago
Guest Editorial: Benchmarking Biotechover 22 years ago
Optimized Nutrient Additives for Fed-Batch CulturesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
2
Streamlining Procurement and Inventory Management Leads to Increased Productivity
3
Managing Risk and Minimizing the Complexity of Your Global Single-Use Supply Chain
4
RNAnalytics Goes Beyond Nanoparticle Analysis at CPHI Frankfurt
5
